文献速递疼痛医学

静脉镁对非心脏手术术后吗啡消耗量的影响:系统评价与荟萃分析及试验序贯分析

The effect of intravenous magnesium on postoperative morphine consumption in noncardiac surgery: A systematic review and meta-analysis with trial sequential analysis.
PubMed 文献 · Eur J Anaesthesiol · 2020-01-01

结果显示静脉镁可显著减少术后24小时吗啡消耗量(均差-5.6 mg,95%CI -7.54至-3.66,P<0.001),延长首次镇痛请求时间,并降低寒战发生率,但对术后24小时疼痛评分、心动过缓和术后恶心呕吐无显著影响。证据质量多为低至极低,异质性较高。

要点

  • 静脉镁可减少非心脏手术术后24小时吗啡消耗量约5.6 mg。
  • 静脉镁延长首次镇痛请求时间并降低寒战发生率。
  • 对疼痛评分、心动过缓及术后恶心呕吐无显著影响。

核心结论

  • 静脉镁作为多模式镇痛的一部分可能减少非心脏手术术后24小时吗啡消耗量并延迟首次镇痛请求时间。
  • 纳入研究质量较低且存在显著异质性。

研究设计与样本

  • 系统评价与荟萃分析,包含试验序贯分析。
  • 检索MEDLINE、EMBASE、CENTRAL从建库至2019年1月。

主要发现

  • 术后24小时吗啡消耗量均差为-5.6 mg(95%CI -7.54至-3.66,P<0.001,I=92%,证据质量低)。
  • 首次镇痛请求时间延长143分钟(95%CI 103至183,P<0.001,I=99%,证据质量低)。
  • 寒战发生率比值比为0.26(95%CI 0.15至0.44,P<0.001,I=35%,证据质量极低)。
  • 术后24小时疼痛评分均差为-0.30(95%CI -0.69至0.09,P=0.13,I=91%,证据质量低)。
  • 心动过缓比值比为1.13(95%CI 0.43至2.98,P=0.80,I=35%,证据质量极低);术后恶心呕吐比值比为0.90(95%CI 0.67至1.22,P=0.49,I=25%,证据质量中等)。

关键数值与推荐

  • 纳入标准为比较静脉镁与安慰剂的随机临床试验,排除观察性研究、病例报告、病例系列和非系统综述。
  • 试验序贯分析认为静脉镁对术后吗啡消耗量的效应结论明确。

临床怎么用

  • 可考虑将静脉镁作为多模式镇痛的一部分用于非心脏手术成人患者,以减少术后24小时吗啡消耗量并延迟首次镇痛需求。
  • 需注意证据质量较低且异质性高,临床决策应结合患者具体情况。

局限性

  • 纳入研究质量较低。
  • 存在显著异质性(如吗啡消耗量I=92%,首次镇痛请求时间I=99%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several studies suggest that systemic magnesium reduces postoperative opioid consumption and the intensity of pain, but others report conflicting results. The efficacy and safety profile of intravenous magnesium in noncardiac surgery remain uncertain. OBJECTIVES: The aim of this review was to investigate the effect of intravenous magnesium on the consumption of postoperative morphine in the first 24 h in adults undergoing noncardiac surgery. DESIGN: Systematic review and meta-analysis with trial sequential analysis. DATA SOURCES: MEDLINE, EMBASE, CENTRAL from their inception until January 2019. ELIGIBILITY CRITERIA: All randomised clinical trials comparing intravenous magnesium versus placebo in noncardiac surgery were systematically searched in the databases. Observational studies, case reports, case series and nonsystematic reviews were excluded. RESULTS: Fifty-one trials (n=3311) were included for quantitative meta-analysis. In comparison with placebo, postoperative morphine consumption at 24-h was significantly reduced in the magnesium group, with a mean difference [95% confidence interval (CI)] of -5.6 mg (-7.54 to -3.66, P < 0.001, I = 92%, level of evidence low). The trial sequential analysis for the effect of magnesium on postoperative morphine consumption was conclusive. Patients who received magnesium had a longer time to the first analgesia request [143 (103 to 183) min, P < 0.001, I = 99%, level of evidence low] and a lower incidence of shivering [0.26 (0.15 to 0.44), P < 0.001, I = 35%, level of evidence very low]. However, no significance differences were demonstrated in postoperative pain scores in the first 24 h (mean difference, 95% CI) -0.30 (-0.69 to 0.09, P = 0.13, I = 91%, level of evidence low), bradycardia (odds ratio, 95% CI) 1.13 (0.43 to 2.98, P = 0.80, I = 35%, level of evidence very low) and postoperative nausea and vomiting (odds ratio, 95% CI) 0.90 (0.67 to 1.22, P = 0.49, I = 25%, level of evidence moderate). CONCLUSION: The current meta-analysis demonstrates that the use of intravenous magnesium as part of multimodal analgesia may reduce morphine consumption in the first 24 h after surgery and delay the time to the first request for analgesia in patients undergoing noncardiac surgery. However, the included studies were of low-quality with substantial heterogeneity. TRIAL REGISTRATION: CRD42018086846.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Ng KT, Yap JLL, Izham IN, et al. The effect of intravenous magnesium on postoperative morphine consumption in noncardiac surgery: A systematic review and meta-analysis with trial sequential analysis. Eur J Anaesthesiol. 2020. PMID: 31977626. doi:10.1097/EJA.0000000000001164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。